CCA
STIM icon

Criterion Capital Advisors’s Neuronetics STIM Stock Holding History

Criterion Capital Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$720 Hold
400
– – ﹤0.01% 336
2024
Q3 		$720 Hold
400
– – ﹤0.01% 336
2024
Q2 		$720 Hold
400
– – ﹤0.01% 336
2024
Q1 		$1.9K Hold
400
– – ﹤0.01% 327
2023
Q4 		$1.16K Buy
+400
New +$631 ﹤0.01% 337

Other funds holding STIM

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Criterion Capital Advisors's STIM Position: Q4 2024 in Review

Criterion Capital Advisors held its Neuronetics (STIM) position steady in Q4 2024 at 400 shares worth $720. The position accounts for ﹤0.01% of the portfolio, ranked #336.

Criterion Capital Advisors first reported a position in STIM in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.9K in Q1 2024. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • Criterion Capital Advisors held 400 shares of Neuronetics worth $720 as of Q4 2024.
  • Criterion Capital Advisors left its Neuronetics share count unchanged in Q4 2024.
  • Neuronetics made up ﹤0.01% of Criterion Capital Advisors's portfolio in Q4 2024, its #336 holding.
  • Criterion Capital Advisors first reported a position in Neuronetics in Q4 2023 and has held it in 5 quarters since.
  • Criterion Capital Advisors's Neuronetics position peaked at $1.9K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.